Trademark Overview
On Tuesday, May 12, 2026, a trademark application was filed for TYRONYX with the United States Patent and Trademark Office. The USPTO has given the TYRONYX trademark a serial number of 99819589. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, May 12, 2026. This trademark is owned by Tyronyx AG. The TYRONYX trademark is filed in the Pharmaceutical Products category with the following description:
pharmaceutical preparations for human use for the treatment and prevention of cancer, infectious diseases, cardiovascular diseases, metabolic disorders, endocrine disorders, neurological disorders, psychiatric disorders, autoimmune diseases, inflammatory diseases, respiratory diseases, gastrointestinal diseases, renal diseases, urologic disorders, dermatological conditions, ophthalmological conditions, hematological disorders, genetic diseases, rare diseases, pain, inflammation, allergies, and musculoskeletal disorders; pharmaceutical preparations, namely, vaccines; biological preparations for medical purposes for the treatment and prevention of cancer, autoimmune diseases, infectious diseases, and genetic diseases
